Qamar Mehwish, Fatima Abeer, Tauseef Ambreen, Yousufzai Muhammad I, Liaqat Ibrahim, Naqvi Qanbar
Physiology, Islam Medical and Dental College, Sialkot, PAK.
Physiology, Services Institute of Medical Sciences, Lahore, PAK.
Cureus. 2024 Apr 9;16(4):e57943. doi: 10.7759/cureus.57943. eCollection 2024 Apr.
Background Non-alcoholic fatty liver disease (NAFLD) has emerged as the single most common chronic non-viral liver disease. The burden of the disease on healthcare-providing services has increased tremendously. Although a liver biopsy is the most authentic laboratory investigation for scoring the disease progression, it is an invasive technique. Researchers are vigorously working to find alternate markers for the scoring purpose. Despite the importance and association of leptin with metabolic syndrome and its related disorders, there have been relatively fewer studies on serum leptin and its association with NAFLD. Objective This study aimed to investigate variations in serum leptin levels between subjects with and without fibrosis in NAFLD and to assess the predictive value of serum leptin levels in NAFLD subjects. Materials and methods The study comprised 130 NAFLD subjects from two tertiary care hospitals in Lahore along with 86 healthy controls that were age, gender, and BMI matched with the subjects. Based on the NAFLD fibrosis score (NFS), the subjects were divided into two sub-groups, subjects with simple steatosis and those with fibrosis. Fasting serum leptin, glucose, and insulin levels were measured using enzyme-linked immunosorbent assay (ELISA). The Kruskal-Wallis test was applied to find differences between the three groups and Fisher's exact test for categorical comparison. To assess the predictive value of serum leptin for steatosis and fibrosis in NAFLD subjects, receiver operation characteristic (ROC) curve analysis was implemented. Results The difference in serum leptin level was statistically highly significant (p-value <0.001), with leptin levels of 10 (17.1) ng/mL among controls, 20.5 (21) ng/mL in simple steatosis, and 21 (28.6) ng/mL in fibrosis. The area under the ROC curve was 0.67 and 0.52 for steatosis and fibrosis, respectively. The cut-off value of 12.2 ng/mL showed 70% sensitivity and 50% specificity for steatosis, while at a threshold of 18 ng/mL, leptin demonstrated 40% sensitivity and specificity for fibrosis. Conclusion In conclusion, this study found that serum leptin levels are higher in NAFLD subjects compared to healthy controls, and it is a good independent predictor for the detection of liver steatosis.
背景 非酒精性脂肪性肝病(NAFLD)已成为最常见的慢性非病毒性肝病。该疾病给医疗服务带来的负担急剧增加。尽管肝活检是评估疾病进展最可靠的实验室检查,但它是一种侵入性技术。研究人员正在积极努力寻找用于评估的替代标志物。尽管瘦素与代谢综合征及其相关疾病的重要性和关联性,但关于血清瘦素及其与NAFLD的关联的研究相对较少。目的 本研究旨在调查NAFLD患者有无纤维化时血清瘦素水平的差异,并评估血清瘦素水平在NAFLD患者中的预测价值。材料和方法 该研究纳入了拉合尔两家三级护理医院的130名NAFLD患者以及86名年龄、性别和BMI与患者匹配的健康对照。根据NAFLD纤维化评分(NFS),将患者分为两个亚组,即单纯性脂肪变性患者和纤维化患者。使用酶联免疫吸附测定(ELISA)测量空腹血清瘦素、葡萄糖和胰岛素水平。应用Kruskal-Wallis检验来发现三组之间的差异,并使用Fisher精确检验进行分类比较。为了评估血清瘦素对NAFLD患者脂肪变性和纤维化的预测价值,进行了受试者操作特征(ROC)曲线分析。结果 血清瘦素水平差异具有高度统计学意义(p值<0.001),对照组瘦素水平为10(17.1)ng/mL,单纯性脂肪变性组为20.5(21)ng/mL,纤维化组为21(28.6)ng/mL。脂肪变性和纤维化的ROC曲线下面积分别为0.67和0.52。12.2 ng/mL的临界值对脂肪变性的敏感性为70%,特异性为50%,而在18 ng/mL的阈值下,瘦素对纤维化的敏感性和特异性为40%。结论 总之,本研究发现NAFLD患者的血清瘦素水平高于健康对照,并且它是检测肝脏脂肪变性的良好独立预测指标。